CDER Quality Agreement Guidance Instructive For Supplement GMPs
This article was originally published in The Tan Sheet
Executive Summary
Attorney Scott Bass expects a drug center guidance document on contract manufacturer quality agreements to “have a profound effect” on dietary supplement firms as well. Daniel Fabricant, FDA’s top supplement official, says the guidance has broad takeaways across regulated product areas.
You may also be interested in...
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
Certain Dri Antiperspirant Sweats It Out Against Big Players
With a thicker, “drip-free” reformulation of Certain Dri launching in January 2014, DSE Healthcare Solutions hopes its clinical-strength roll-on antiperspirant will appeal to more consumers with hyperhidrosis as well as those concerned about but not diagnosed with excessive perspiration.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: